AMRUTANJANNSEAMRUTAJAN HEALTH LTD· PharmaceuticalsMinimalNeutral
Announced Wed, 7 Oct, 2026 · 10:25 IST

Compliance certificate submitted under SEBI DP Regulations for Sep 2026 quarter

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.7%Reaction day
₹524.45
prior close
₹522.50
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-0.5% vs market
Pharmaceuticals peers, median of 170sector-0.3%-0.4% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.1
15m
-0.1
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.7-0.2-0.5-0.3-0.4
Next day
-3.8-3.0-0.8-2.7-1.0
2d
-2.4-2.7+0.4-2.7+0.3
3d
-3.7-1.9-1.8-2.6-1.1
4d
-3.5-1.7-1.8-3.0-0.5
5d
-3.9-1.0-2.9-2.9-1.0
1w
-1.4-2.0+0.6-3.5+2.1
15d
-6.0pendingpending-3.4-2.6
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Amrutanjan Health Care has submitted a compliance certificate under Regulation 74(5) of the SEBI Depositories and Participants Regulations 2018. The certificate was issued by its Registrar and Share Transfer Agent, Cameo Corporate Services Limited, for the quarter ended 30 September 2026. This is a standard quarterly filing confirming details of securities held in demat form.

Likely market impact

Routine regulatory compliance filing with no material impact on the stock or shareholders.